Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients.

Abstract:

BACKGROUND:Long-term oral corticosteroid (OCS) therapy and related adverse events are associated with a significant burden on patients and healthcare resources. METHODS:This subgroup analysis of a randomized, open-label, parallel-group study evaluated the OCS-sparing effect of omalizumab (OMA) added to optimized asthma therapy (OAT), compared with OAT alone. Patients (12-75 years) with severe allergic asthma, uncontrolled despite GINA 2004 Step 4 therapy, received OMA or OAT for 32 weeks. The change from baseline in OCS use by Week 32 in patients requiring maintenance OCS at baseline was assessed in terms of percent OCS dose change and numbers of patients with reduced/stopped or maintained/increased OCS. RESULTS:Eighty-two patients were receiving maintenance OCS at baseline (OMA/OAT n = 59, OAT n = 23). Change from baseline in mean maintenance OCS dose at Week 32 was significantly greater in the OMA/OAT group compared with the OAT group (-45% vs. + 18.3%, p = 0.002). In the OMA/OAT group, 37 patients (62.7%) reduced/stopped OCS use at Week 32, compared with seven patients (30.4%) receiving OAT (p = 0.013). Improvements in other efficacy outcomes were seen at Week 32 in the OMA/OAT group, irrespective of OCS use. An investigator global evaluation of treatment effectiveness at Week 16 was an effective predictor of persistent treatment response at 32 weeks for the majority of OMA/OAT patients (93%), also irrespective of OCS use. CONCLUSION:In this open-label study of patients with severe allergic asthma, OMA/OAT therapy reduced maintenance OCS use, compared with OAT alone. Improvements in efficacy measures were observed in the OMA/OAT group, irrespective of OCS change. CLINICALTRIALS.GOV IDENTIFIER: NCT00264849.

journal_name

Curr Med Res Opin

authors

Siergiejko Z,Świebocka E,Smith N,Peckitt C,Leo J,Peachey G,Maykut R

doi

10.1185/03007995.2011.620950

subject

Has Abstract

pub_date

2011-11-01 00:00:00

pages

2223-8

issue

11

eissn

0300-7995

issn

1473-4877

journal_volume

27

pub_type

杂志文章,随机对照试验
  • Systematic literature review and meta-analysis of dual therapy with fenofibrate or fenofibric acid and a statin versus a double or equivalent dose of statin monotherapy.

    abstract:OBJECTIVE:To assess the efficacy of fenofibrate and statin dual therapy versus a double or equivalent dose of statin monotherapy. METHODS:A systematic literature search and meta-analysis was performed for publications before 1 January 2014 in MEDLINE, Embase, and BIOSIS Previews, among others. RESULTS:The difference ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析,评审

    doi:10.1185/03007995.2015.1098597

    authors: Ouwens MJ,Nauta J,Ansquer JC,Driessen S

    更新日期:2015-12-01 00:00:00

  • GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin.

    abstract:OBJECTIVES:GOAL (Gauging Osteoarthritis [OA] with Limbrel*), an open-label, post-marketing study was performed to determine the overall efficacy and gastrointestinal (GI) tolerability of flavocoxid, a novel, plant-based, anti-inflammatory medication, in a 'real world' clinical practice setting. To this end, the study e...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007991003694522

    authors: Pillai L,Burnett BP,Levy RM,GOAL Study Cooperative Group.

    更新日期:2010-05-01 00:00:00

  • Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.

    abstract:OBJECTIVE:In a 4-week, double-blind, placebo-controlled study, the attention-promoting agent modafinil improved symptoms of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents and was well tolerated. To assess the continued efficacy of modafinil and obtain additional safety data, an 8-week, open...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/030079906X148300

    authors: Boellner SW,Earl CQ,Arora S

    更新日期:2006-12-01 00:00:00

  • Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias.

    abstract:OBJECTIVE:To investigate the efficacy of the cholesterol absorption inhibitor ezetimibe in patients with refractory familial hyperlipidaemia or intolerant to statin therapy. METHODS:This prospective study assessed the safety and efficacy of ezetimibe in 200 patients with refractory familial hyperlipidaemias not achiev...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/030079905X28872

    authors: Wierzbicki AS,Doherty E,Lumb PJ,Chik G,Crook MA

    更新日期:2005-03-01 00:00:00

  • A clinical trial of glycosaminoglycan-peptide complex ('Rumalon') in patients with osteoarthritis of the knee.

    abstract::A clinical trial was undertaken in 50 patients with osteoarthritis of the knee to assess the therapeutic value of glycosaminoglycan-peptide complex in treatment. The first year consisted of a randomized, double-blind, placebo-controlled, parallel-group trial (25 patients in each group), after which all patients receiv...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998709112416

    authors: Katona G

    更新日期:1987-01-01 00:00:00

  • Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.

    abstract:BACKGROUND:Patients with hypereosinophilic syndrome (HES) vary considerably in their clinical presentation with regard to the severity and pattern of end-organ involvement. Clinical manifestations range from nonspecific symptoms to life-threatening, multisystem damage caused by eosinophil infiltration and local release...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2010.493132

    authors: Schwartz LB,Sheikh J,Singh A

    更新日期:2010-08-01 00:00:00

  • Surveying general practitioners: a new avenue.

    abstract:BACKGROUND:The validity of opinions expressed in questionnaire surveys diminishes with lower response rates. Recent research suggests that general practitioners (GPs) are more likely to respond to questionnaire surveys if they are motivated to do so because the subject of the survey is perceived as relevant to the prac...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079903125002900

    authors: Jiwa M,Coker AE,Bagley J,Freeman J,Coleman M

    更新日期:2004-03-01 00:00:00

  • Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.

    abstract:OBJECTIVE:Evaluation of the safety and efficacy of insulin detemir (IDet) in the observational and non-interventional PREDICTIVE study. METHODS:A total of 2923 patients with type 1 or 2 diabetes on basal-bolus regimens were followed for 6 months: Group (1) NPH + human insulin (HI) bolus switching to IDet + analogue bo...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990903262885

    authors: Hermansen K,Dornhorst A,Sreenan S

    更新日期:2009-11-01 00:00:00

  • Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.

    abstract:OBJECTIVE:To determine resource utilization in controller naïve children diagnosed with asthma receiving initial therapy with fluticasone propionate (FP) and salmeterol (SAL) in a single inhaler (FSC), FP alone, montelukast (MON), inhaled corticosteroid (ICS) + SAL from separate inhalers, or ICS + MON. RESEARCH DESIGN...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X89711

    authors: Stempel DA,Riedel AA,Carranza Rosenzweig JR

    更新日期:2006-03-01 00:00:00

  • Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database.

    abstract:OBJECTIVE:To compare the risk of developing uveitis in patients initiating anti-tumor necrosis factor (anti-TNF) agents (adalimumab, etanercept, and infliximab) for ankylosing spondylitis (AS). METHODS:Anti-TNF-naive patients with a diagnosis of AS and without a history of uveitis (N = 2115) who subsequently initiated...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2014.969368

    authors: Wendling D,Joshi A,Reilly P,Jalundhwala YJ,Mittal M,Bao Y

    更新日期:2014-12-01 00:00:00

  • Efficacy and tolerability of cefuroxime axetil in patients with upper respiratory tract infections.

    abstract::A study was carried out in general practice to assess the clinical effectiveness and tolerability of the oral cephalosporin, cefuroxime axetil, in the treatment of 369 patients presenting with acute infections of the upper respiratory tract. The main diagnoses were tonsillitis, pharyngitis, sinusitis and otitis media....

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007998709108965

    authors: Griffiths GK,VandenBurg MJ,Wight LJ,Gudgeon AC,Kelsey M

    更新日期:1987-01-01 00:00:00

  • A common humoral background of intraocular and arterial blood pressure dysregulation.

    abstract:BACKGROUND:It has been postulated that intraocular pressure, an important glaucoma risk factor, correlates positively with arterial blood pressure (blood pressure). However, results of experimental and clinical studies are often contradictory. It is hypothesized that, in some hypertensive patients, disturbances in intr...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2017.1415203

    authors: Skrzypecki J,Grabska-Liberek I,Przybek J,Ufnal M

    更新日期:2018-03-01 00:00:00

  • Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension.

    abstract:OBJECTIVE:Most patients with hypertension require antihypertensive combination therapy to achieve BP control. This study investigated the safety and efficacy of the direct renin inhibitor aliskiren combined with the calcium channel blocker amlodipine. METHODS:Overall, 556 patients with hypertension (msDBP > or =95-<11...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007990902785845

    authors: Littlejohn TW 3rd,Trenkwalder P,Hollanders G,Zhao Y,Liao W

    更新日期:2009-04-01 00:00:00

  • Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.

    abstract:BACKGROUND:Thymectomy is a standard treatment of myasthenia gravis (MG). Immunomodulating agents are frequently given during the post-thymectomy latency period until complete remission is fully consolidated, but serious side effects is a relevant clinical problem for patients on long-term immunomodulating treatment. O...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/030079906X104650

    authors: Ponseti JM,Azem J,Fort JM,López-Cano M,Vilallonga R,Gamez J,Armengol M

    更新日期:2006-05-01 00:00:00

  • Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies.

    abstract:BACKGROUND:Insulin resistance alone does not result in the development of type 2 diabetes; progressive dysfunction of pancreatic islet alpha and beta cells, which results in inadequate control of hyperglycemia, must be present for the disease to develop. Because of these defects, meal-stimulated insulin secretion from ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/030079906x167336

    authors: Meece J

    更新日期:2007-04-01 00:00:00

  • Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review.

    abstract:BACKGROUND:Development of a second primary malignancy (SPM) after an index esophageal cancer is fairly rare, primarily due to decreased survival in patients with esophageal cancer. However, with advances in early detection and therapy, the number of long-term survivors is increasing, as is the incidence of SPMs in this...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2013.816276

    authors: Nandy N,Dasanu CA

    更新日期:2013-09-01 00:00:00

  • Improving SAR symptoms with levocetirizine: evaluating active and placebo effects in pollen challenge vs. natural exposure studies.

    abstract:OBJECTIVE:Despite a plethora of published data on levocetirizine, no meta-analyses exist on the effect of study design, and covariates like age, gender, and baseline symptom severity on treatment response. The objective of this study was the efficacy of levocetirizine 5  mg tablets and matching placebo at reducing alle...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1185/03007995.2010.537319

    authors: Boev R,Song D,Bedenbaugh A,Haeusler JM

    更新日期:2011-01-01 00:00:00

  • Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety.

    abstract:PURPOSE:To compare the efficacy and safety of the concomitant administration of travoprost 0.004% once daily and brinzolamide 0.1% twice daily with those of a fixed combination of latanoprost 0.005%/timolol 0.5% once daily. RESEARCH, DESIGN AND METHODS:Forty-four patients with primary open-angle glaucoma or ocular hyp...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/030079904125004529

    authors: Martinez-de-la-Casa JM,Castillo A,Garcia-Feijoo J,Mendez-Hernandez C,Fernandez-Vidal A,Garcia-Sanchez J

    更新日期:2004-09-01 00:00:00

  • Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients.

    abstract:BACKGROUND:Patients with chronic myeloid leukemia (CML) who do not adhere to treatment may experience suboptimal outcomes. OBJECTIVE:To examine the association between adherence with imatinib and direct healthcare costs and resource utilization in a large group of privately insured CML patients. PATIENTS AND METHODS:...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990903396469

    authors: Wu EQ,Johnson S,Beaulieu N,Arana M,Bollu V,Guo A,Coombs J,Feng W,Cortes J

    更新日期:2010-01-01 00:00:00

  • Double-blind, placebo-controlled, multi-centre trial of the efficacy and tolerance of niflumic acid ('Nifluril') capsules in the treatment of tonsillitis in adults.

    abstract::A double-blind, placebo-controlled study was carried out in 231 adult patients suffering from acute diffuse pharyngitis or acute tonsillitis with fever and dysphagia to assess the effectiveness of niflumic acid combined with standard antibiotic therapy in relieving pain and inflammation. Patients were allocated at ran...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007999009112689

    authors: Sauvage JP,Ditisheim A,Bessede JP,David N

    更新日期:1990-01-01 00:00:00

  • Efficacy and safety of luseogliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, placebo-controlled, phase II study.

    abstract:OBJECTIVE:Luseogliflozin is a novel sodium glucose cotransporter 2 inhibitor for type 2 diabetes mellitus (T2DM) treatment. An exploratory Phase II study was conducted to assess the efficacy and safety of several doses of luseogliflozin in Japanese T2DM patients. PATIENTS AND METHODS:Japanese T2DM patients aged 20-74 ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007995.2014.901943

    authors: Seino Y,Sasaki T,Fukatsu A,Sakai S,Samukawa Y

    更新日期:2014-07-01 00:00:00

  • Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.

    abstract:OBJECTIVE:To determine the efficacy and safety of lumiracoxib for knee osteoarthritis (OA). METHODS:This was a 13-week, multicentre, randomized, double-blind, double-dummy, placebo-controlled study. Males or females aged >/= 18 years with primary knee OA received lumiracoxib 100 mg od, lumiracoxib 100 mg od with a loa...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079905x38196

    authors: Lehmann R,Brzosko M,Kopsa P,Nischik R,Kreisse A,Thurston H,Litschig S,Sloan VS

    更新日期:2005-04-01 00:00:00

  • Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus.

    abstract:OBJECTIVE:To compare glycemic goal achievement (HbA(1c) < 7%) in type 2 diabetes patients receiving initial metformin plus pioglitazone combination therapy and initial metformin monotherapy augmented with pioglitazone in a cohort follow-up study. RESEARCH DESIGN AND METHODS:Adult patients were identified from the Inge...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2010.536755

    authors: Pandya BJ,Bron M,McCall T,Yu AP,Chen KS,Mattson ME,Wu EQ

    更新日期:2011-01-01 00:00:00

  • Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.

    abstract:BACKGROUND:Exenatide, an incretin mimetic for adjunctive treatment of type 2 diabetes (T2DM), reduced hemoglobin A(1c) (A1C) and weight in clinical trials. The objective of this study was to evaluate the effects of > or = 3 years exenatide therapy on glycemic control, body weight, cardiometabolic markers, and safety. ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079908x253870

    authors: Klonoff DC,Buse JB,Nielsen LL,Guan X,Bowlus CL,Holcombe JH,Wintle ME,Maggs DG

    更新日期:2008-01-01 00:00:00

  • Double-blind parallel study of a combination of chlorthalidone 50 mg and triamterene 50 mg in patients with mild and moderate hypertension.

    abstract::In a double-blind, partial cross-over study of 141 patients with mild to moderate hypertension, chlorthalidone 50 mg was compared with chlorthalidone 50 mg/triamterene 50 mg combination treatment. The study assessed clinical efficacy in the reduction of blood pressure, and safety with regard to serum potassium concent...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007999609111560

    authors: Spiers DR,Wade RC

    更新日期:1996-01-01 00:00:00

  • Controlled study on the anxiolytic activity of a newly-developed benzodiazepine, metaclazepam.

    abstract::A double-blind, parallel group study was carried out in 50 patients with an anxiety disorder to compare the anxiolytic efficacy and tolerability of a recently developed benzodiazepine, metaclazepam, with that of bromazepam. Patients were allocated at random to receive treatment for 2 weeks with either 15 mg metaclazep...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998809111129

    authors: Marano P,Patti F,Nicoletti F

    更新日期:1988-01-01 00:00:00

  • Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective.

    abstract:OBJECTIVE:To review the pharmacoeconomic literature evaluating use of antihistamines in treating allergic rhinitis (AR) in the US. METHODS:Three independent reviewers conducted a comprehensive search of the current literature with PubMed. They identified articles describing original research comprising US cost analyse...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990902875992

    authors: Hay JW,Kaliner MA

    更新日期:2009-06-01 00:00:00

  • Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma.

    abstract:BACKGROUND:Many children with severe persistent allergic (IgE-mediated) asthma remain inadequately controlled despite treatment with high-dose inhaled corticosteroids (ICS) plus a long-acting beta(2)-agonist (LABA). RESEARCH AND DESIGN METHODS:This pre-specified analysis of a randomized, double-blind, placebo-controll...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/03007991003771338

    authors: Kulus M,Hébert J,Garcia E,Fowler Taylor A,Fernandez Vidaurre C,Blogg M

    更新日期:2010-06-01 00:00:00

  • Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs.

    abstract:BACKGROUND:Low-dose acetylsalicylic acid (ASA; aspirin; 75-325 mg/day) is effective for the prevention of cardiovascular events, and its use in this indication is rapidly increasing. However, the use of ASA and, indeed, other non-steroidal anti-inflammatory drugs (NSAIDs) is limited by the incidence of adverse gastrodu...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990903212682

    authors: Yeomans ND,Hawkey CJ,Brailsford W,Naesdal J

    更新日期:2009-11-01 00:00:00

  • Clinical burden of venous thromboembolism.

    abstract:BACKGROUND:Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism (PE), is a major cause of morbidity and mortality. VTE is a common disorder, with an estimated annual incidence of approximately 5-12 persons per 10,000. The prognosis for patients who develop VTE is exacerbated by the r...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2010.516090

    authors: Ruppert A,Lees M,Steinle T

    更新日期:2010-10-01 00:00:00